Moderna secures up to 24 million RSV vaccine dose contract with Europe - Pharmaceutical Technology

Over 156,000 adults in Europe are hospitalised each year due to RSV, a virus that can cause severe lung issues. Over 156,000 adults in Europe are hospitalised each year due to RSV, a virus that can cause severe lung issues. According to the EC, the procurement is an important step in reducing the burden on healthcare services. Credit: Billion Photos/Shutterstock.com. Moderna has agreed a contract with the European Commission (EC) that will see tens of millions of respiratory syncytial virus (RSV) vaccine doses accessible to member countries in time for the 2026-2027 winter season. Upon the request of six unnamed…

Source: Pharmaceutical Technology